tradmap

ASTH Astrana Health, Inc.

$36.95 +1.09%

Data as of close

Industrials · Services-Management Consulting Services

Astrana Health, Inc. (ASTH) is an industrial company in the Services-Management Consulting Services industry, with a market capitalization of $2.1 billion. Shares last traded at $36.95, 28.4% below their 52-week high. Over the past year the stock is up 16.2%. ASTH trades at a price-to-earnings ratio of 50.79, above the Services-Management Consulting Services median of 22.40. Net profit margin is 1.1%, below the peer median of 3.7%. Revenue grew 56.4% year over year.

Market Cap
$2.1B
Shares Out
55.7M
EPS (TTM)
$0.82
P/E (TTM)*
50.79
P/S Ratio
0.54
P/B Ratio
2.48
Dividend / Share
—
Dividend Yield
—
52-Week High
$51.60
52-Week Low
$18.09
Volume (venue)
9,857
Avg Vol (3m, venue)
17,391.698

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-0.75%
1M
+2.95%
3M
+2.24%
6M
+5.60%
YTD
+48.87%
1Y
+16.23%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
49.48
SMA (50)
$37.03
SMA (200)
$33.88
Price vs SMA50
-0.22%
Price vs SMA200
+9.06%
ATR (14)
$1.84

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$3.8B
Net Income
$41M
Gross Margin
0.0%
Operating Margin
2.6%
Net Margin
1.1%
Return on Equity
4.9%
Return on Assets
1.8%
Current Ratio
1.23
Debt / Equity
1.06
Revenue Growth (YoY)
+56.4%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

ASTH Dividend History

Per-share growth (5y CAGR)
-34.9%
Payout ratio (latest FY)
33%
Fiscal year endTotal dividends paidPer share*Payout ratio
2025-12-31 $8M $0.16 33%
2024-12-31 $4M $0.08 8%
2023-12-31 $62M $1.32 107%
2022-12-31 $14M $0.31 31%
2021-12-31 $31M $0.68 68%
2020-12-31 $51M $1.37 136%
2019-12-31 $62M $1.70 437%
2018-12-31 $18M $0.47 164%

*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.

Compare payers on the highest-dividend-yield screener.

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.40 2026-08-10
Q1 2025 $0.29 2026-05-08
Q4 2025 (derived) $0.12 2026-03-12
FY 2025 $0.46 2026-03-12
Q3 2025 $0.01 2025-11-10
Q2 2025 $0.19 2025-08-07

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Management Consulting Services peers

ASTH vs 14 industry peers (Services-Management Consulting Services), by market cap. Data as of close

P/E vs peers
50.79 / 22.40 med
+127% premium
P/S vs peers
0.54 / 1.16 med
-54% discount
Net margin vs peers
1.1% / 3.7% med
below median
1–14 of 14
BAHBooz Allen Hamilton Holding Corp$10.4B13.320.957.1%-0.52%
GGenpact Ltd$6.8B11.681.3011.1%+2.28%
FCNFti Consulting, Inc$5.2B22.401.315.9%+4.89%
EXPOExponent Inc$4.1B36.836.5117.7%+7.93%
HURNHuron Consulting Group Inc.$3.2B30.471.815.9%+0.21%
ASTHAstrana Health, Inc.$2.1B50.790.541.1%+1.09%
ICFIIcf International, Inc.$1.8B19.950.974.9%+3.43%
BWMNBowman Consulting Group Ltd.$744M100.811.411.4%+0.00%
ONTOnterris, Inc.$554M—0.72-1.4%+5.84%
ROMARoma Green Finance Ltd$335M———+2.77%
PPHCPublic Policy Holding Company, Inc.$329M—1.76-20.9%+5.12%
HCKTHACKETT GROUP, INC.$328M19.481.145.9%+2.65%
IIIInformation Services Group Inc.$299M24.921.184.7%+2.95%
RMRRMR GROUP INC.$290M14.650.412.8%+1.74%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.